Frequency of the rs 14035 polymorphism of RAN gen in recurrent pregnancy loss: A case-control study by Mortazavifar, Zahrasadat et al.
International Journal of Reproductive BioMedicine
Volume 18, Issue no. 5, https://doi.org/10.18502/ijrm.v13i5.7156
Production and Hosting by Knowledge E
Research Article
Frequency of the rs 14035 polymorphism
of RAN gen in recurrent pregnancy loss:
A case-control study
Zahrasadat Mortazavifar1 M.Sc., Hamidreza Ashrafzadeh2 Ph.D. Candidate,
Seyed Morteza Seifati1 Ph.D., Nasrin Ghasemi2 M.D., Ph.D.
1Medical Biotechnology Research Center, Ashkezar Branch, Islamic Azad University, Ashkezar,
Yazd, Iran.
2Abortion Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of
Medical Sciences, Yazd, Iran.
Abstract
Background: Genetic factors could account for recurrent pregnancy loss (RPL). The
RAN gene is a member of the ”large RAS family” and a small GTPase that is essential
for the translocation of Ribonucleic acid (RNA) and proteins through the nuclear
pore. Mutation in the RAN constitutive gene could stop DNA synthesis and alter the
expression of genes in the uterus, likely playing a role in recurrent miscarriage.
Objective: The aim was to investigate the frequency of RAN (rs 14035) polymorphism
in women with RPL compared with women without abortion history.
Materials and Methods: In this case-control study, 100 women with at least two
consecutive miscarriages before the 20th wk of gestation and having spouses with
karyotype and normal sperm parameters as the case group and 100 women with
no history of abortion and having at least one successful pregnancy and normal
delivery as the control group. The groups were age matched (20-40 yr). The rs
14035 polymorphism of RAN gene was investigated by Polymerase Chain Reaction-
Restriction Fragment Length poly morphism technique and the frequency of which was
compared between the two groups.
Results: The frequency of TT, TC, and CC genotypes of RAN gene polymorphism in
the case group were 9%, 40%, and 51%, respectively, and in the control group were
11%, 38%, and 51%, respectively. There was no significant difference in the genotypes
between two groups (p = 0.882).
Conclusion: According to our results, it seems that RAN polymorphism (rs 14035) is not
associated with the risk of RPL in this study population.
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1. Introduction
Recurrent pregnancy loss (RPL) is one of the
most common complications of pregnancy that is
defined as two or more consecutive miscarriages
occurring one in every 300 pregnancies (1, 2).
One possible cause of RPL is impaired miRNA
genes processing. The presence of the RAN
gene polymorphism (rs 14035) may increase the
risk of recurrent miscarriages. RAN gene is a
member of the ”large family of RAS” and is
a small essential GTPase for the translocation
of RNA and proteins through the nuclear pore.
It is also involved in mitosis as well as DNA
synthesis and promoting the cell cycle. Mutation
in the RAN gene, which encodes the RAN-
producing gene, disrupts DNA synthesis and
can play a crucial role in abortion (3, 4).
Previous studies showed the effect of genetic
changes on inducing RPL as a major pregnancy
complication. However, there are still so many
controversies around these cause and effect (5-
9).
miRNAs regulate gene expression at the
post-transcriptional stage by suppressing
translation or mRNA reduction (10). About
30% of human genes are the targets of
protected miRNAs, hence showing that miRNAs
are the key regulators in many biological
pathways (11). Previous studies have shown
a significant relationship between recurrent
miscarriage and rs 14035 in women with RPL
(12-14).
Since the polymorphism of a gene may
be not the same in different populations
and geographical areas, this study
aimed to determine the frequency and
relationship of rs 14035 with RPL in women
referred to Yazd Reproductive Sciences
Institute.
2. Materials and Methods
In this case-control study, blood samples from
100 women aged 20-40 yr with at least two or
more idiopathic miscarriages were collected. All
cases were referred to the Yazd Reproductive
Sciences Institute between March and December
2018.
The control group (n = 100) consisted of 20-
40 yr-old women with no history of abortion and
having at least one successful pregnancy and
normal delivery.
All women with cytogenetic problems,
anatomical abnormalities in the reproductive tract,
immunological disease, hormonal abnormalities
(including thyroid and prolactin disorders),
infection, history of cancer, and spouses with
abnormal karyotype or impaired semen analysis
were excluded.
2.1. DNA extraction
A total of 200 DNA samples extracted from
2 μl blood specimens from the case and
control groups were studied. As previously
reported ”RNA was isolated from blood
samples using the QuantiTectR, RNeasy Micro
kit (Qiagen Europe, Germany) according to
the manufacturer’s instructions. The RNA
concentration was measured by NanoDrop
spectrophotometer and adjusted to a
concentration of 1000 ng/μl. Then, cDNA
was synthesized by a RevertAid First Strand
cDNA synthesis kit (Thermo Fisher Scientific
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Inc.), according to the manufacturer’s guides.
The reverse transcription was performed
in 20 μl reactions for 60 min at 42°C,
followed by 70°C for 5 min to put the reverse
transcriptase out of action. The products of
reverse transcription reaction were straightly
used in polymerase chain reaction (PCR)
in a separate step to amplify the targets
(15)”.
2.2. Polymerase chain reaction
The final volume of PCR reactions was
assumed to be 25 µl in this study so that
the mastermix (12.5 µl), DNA (3 µl), forward
primers (1 µl), reverse primers (1 µl), and water
(7.5 µl) can reach to a volume of 25 µl. It was
then mixed in 0.2 microtubes and placed
in a thermocycler followed by vortex and
microfusion, and based on the temperature
program given to the device, the given parts
were reproduced. When the PCR reaction was
completed, we used electrophoresis to confirm
the PCR product and to ensure that it was not
contaminated. The microtubes were removed
from the apparatus, and 5 µl of the reaction
product plated on 2% agarose gel was sampled
and subjected to 95 V for 1 hr. The agarose
gels were then photographed and analyzed
by gel docking. Electrophoresis results were
single band in the 152 bp region without any
specific band. After completing the samples
and examining the products by electrophoresis
and ensuring the specific amplification of the
PCR product fragment for subsequent steps,
it was stored at -20°C. PCR was performed
again if the samples lacked bands or had poor
bands.
After performing PCR reaction for all the
patients and controls, the final study was
performed by PCR-RFLP (Restriction fragment
length polymorphism) technique using BSL1-
restricting enzyme. Following the optimization
of enzymatic digestion conditions, all samples
were subjected to this enzyme and then plated
on 2% agarose gel. The optimal temperature
for enzymatic digestion of PCR products by
the BSL1 enzyme is 55°C. The PCR-RFLP
procedure was performed as follows: 18 µl of
water was poured into a microtube and then 2
µl of enzyme buffer and 1 µl of enzyme were
added. Next, 10 µl of PCR product was added
and vertex was performed. The specimens
were then incubated in the incubator for
3 hr at 55°C. Finally, 10 µl of the reaction
product was applied to 2% agarose gel
and exposed to 100 V for 1 hr in order to
test the product and then placed in a dock
gel to see the result of the gel test (Figure
1).
In the present study, regarding the enzymatic
fragmentation status (CCNNNNNNNGG),
by conducting PCR-RFLP technique
using BSL1 enzyme and performing gel
electrophoresis of reaction products, we
expected to observe three different patterns
as follows:
A. In the single-band 152 observation mode
after enzymatic digestion, we have the TT
allele.
B. In the two-bands (127 + 25) observation
mode, we have CC allele.
C. In the three-bands (252 + 127 + 25)
observation mode, we have CT allele.
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Figure 1. Extracts from the enzymatic digestion of PCR product of polymorphism rs14035. Columns 1, 2, and 3 of the fragments
obtained from enzymatic digestion of the healthy sample. Column 4 indicates Ladder. Columns 5, 6, and 7 of the fragments
obtained from enzymatic digestion of the patient sample.
2.3. Ethical consideration
The research proposal was approved by
the Ethics Committee of Yazd Reproductive
Sciences Institute, Yazd, Iran (Code:
IR.SSU.RSI.REC.1397.024). All participants’
information was extracted from their hospital
records maintaining confidentiality and entered
into the study data collection form.
2.4. Statistical analysis
SPSS software (Statistical Package for the
Social Sciences, version 20.0, SPSS Inc, Chicago,
Illinois, USA) was used for statistical analysis.
Statistical comparisons were performed by Chi-
Square and Students’ t tests. P-value < 0.05 was
considered as statistically significant.
3. Results
In this study, DNA were extracted from 200
peripheral blood (n = 100/each group). The mean
age of the samples in the case and control
group were 28.57 ± 4.76, and 27.67 ± 4.09 yr,
respectively (p = 0.16). The residential place of
case group were 31% from Yazd (n = 31) and 69%
(n = 69) was elsewhere (outside the province) (p <
0.001). All of the participants in the control group
were from Yazd province (100%).
In the case group, 73 (73%) had a history of
abortion in the first trimester of pregnancy, 8 (8%)
in the second and third trimesters of pregnancy,
and 19 (19%) had a history of abortion in all
trimesters. Only 7 (7%) had a history of ectopic
pregnancy. Moreover, 9% had a history of stillbirth,
23% a history of partial hydatidiform mole, 25%
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primary infertility, and 9% had the secondary
infertility. In addition, 41% of the couples in
the case group had consanguinity and 59%
had no consanguineous marriage. There was
no significant difference between the genotypic
frequency of rs14035 polymorphism in the three
CC, CT, and TT genotypes in the case and control
groups (p = 0.882) (Table I).
Allele C frequency was 142 (71%) in the women
with recurrent miscarriages and 140 (70%) in the
control group. The number of allele T in the
case group was 58 (29%) and in the control
group 60 (30%). Statistical comparison showed
no significant difference between the frequency
of alleles C and T and the polymorphism studied
in the case and control participants (Odds ratio:
0.953; CI: 0.620-1.465; p = 0.826).
The frequency of abortion in the case group
(n=100) was as follows: 73 women (73%) had
a history of miscarriage in the first trimester, 8
(8%) had a history of miscarriage in second and
third trimesters and 19 (19%) had a history of
both types of miscarriage. Statistical analysis
using the Chi-square test did not show a
significant relationship between abortion time
and genotype in our participants (p = 0.528)
(Table II).
According to the results, no significant
relationship was identified between abortion
time, history of stillbirth, ectopic pregnancy, and
frequency of hydatidiform mole pregnancy with
genotypes of the participants (p = 0.528, p =
0.905, p = 0.688, and p = 0.738, respectively)
(Table III).
Table I. Distribution of RAN (rs14035) polymorphism genotype frequency in the case and control groups
Genotype Case group (n = 100) Control group (n = 100) P-value*
CC 51 (51%) 51 (51%)
CT 40 (40%) 38 (38%)
TT 9 (9%) 11 (11%)
0.882
*Chi-square test
Table II. Comparison of the relationship between abortion time and RAN (rs14035) polymorphism genotype frequency in the case
group (n = 100)
Genotype/Abortion time First trimester (n = 8) Second and third
trimesters (n = 73)
First, second, and third
trimester (n = 19)
P-value
TT 1 (11.1%) 7 (77.8%) 1 (11.1%)
CC 3 (5.9%) 35 (68.6%) 13 (25.5%)
CT 4 (10%) 31 (77.5%) 5 (12.5%)
0.528
Chi-Square test, Abortion time
Table III. Comparison of the relationship between RAN (rs14035) polymorphism genotype frequency and history of stillbirth,
ectopic pregnancy history, and hydatidiform moles in the case group (n = 100)
TT CC CT P-value
History of stillbirth (n = 9) 1 (11.1%) 5 (9.8%) 3 (7.5%) 0.90
History of ectopic pregnancy (n = 7) 0 (0%) 4 (7.8%) 3 (7.5%) 0.68
History of hydatidiform moles (n = 23) 3 (33.3%) 11 (21.6%) 9 (22.5%) 0.73
Chi-square test
https://doi.org/10.18502/ijrm.v13i5.7156 Page 363
International Journal of Reproductive BioMedicine Mortazavifar et al.
4. Discussion
This study investigated the association of
RAN polymorphism with the risk of recurrent
miscarriage. This gene is involved in biogenesis
and miRNA processing and may be involved in
the risk of spontaneous abortion. The results of
this study showed no association between the
frequency of RAN (rs14035) gene polymorphism
and the risk of recurrent spontaneous miscarriage
in the study population.
The biogenesis process of miRNAs is
multistep that begins from the cell nucleus
and then continues to the cytoplasm through
the transcriptional stage. A study by Rah and
colleagues have shown that polymorphisms
of miRNA-encoding genes may lead to the
formation of different secondary structures
in miRNAs, which may therefore affect
the degree of miRNA stability (16). The
miRNAs, small RNA molecules, and encoding
affect the pathway of gene expression
regulation by interfering with trophoblast
cell proliferation, regulating cell proliferation,
placental growth, and embryogenesis. In this
regard, new insights address the pathologic
pathway of idiopathic recurrent miscarriages
(17).
To date, few studies have been performed
on the role of the RAN gene in the human
reproductive system. In a case-control study
by Jung and colleagues, the association of
different types of microRNA biosynthesis
system with idiopathic spontaneous abortion
was investigated. Using PCR-RFLP technique,
they confirmed the association between
these polymorphisms and the increased
incidence of recurrent miscarriage by
examining 238 women in the control group
and 338 women with two-time history of
idiopathic spontaneous abortion (13). However,
their findings were different from those of
ours.
In 2017, Fu and colleagues in China explored
the relationship between the polymorphisms
of genes involved in microRNA biosynthesis
(DICER, DROSHA, and RAN) with unexplained
recurrent miscarriage in 217 women with a
history of miscarriage. These women were
compared to 390 healthy unmarried women
as the case group by PCR-RFLP technique.
Results of this study revealed that although
DICER rs3742330/RAN rs14035 GG/TT + TC
combinations were significantly higher in the
group with recurrent miscarriage, no significant
difference was identified between the two groups
(18).
Moreover, Fallah-Sohy and colleagues
conducted a case-control study on genotyping
of DICER gene polymorphism in 20 healthy
women and 50 women with RPL using Tetra
ARMS (Amplification Refractory Mutation
System) PCR technique. They determined
RAN polymorphism genotype in 10 healthy
women and 40 women with unexplained
spontaneous recurrent miscarriage by PCR
and sequencing method. The results of this
study revealed a significant relationship between
recurrent spontaneous miscarriage and RAN
polymorphism (rs14035), but this complication
was not correlated with DICER polymorphism
(rs3742330) (14).
A descriptive study evaluated the association
between polymorphism of RAN (rs14035)
and XPO5 (rs2257082) genes with recurrent
miscarriage in 100women suffering from recurrent
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miscarriage and 100 healthy women by PCR-
RFLP. The findings demonstrated that XPO5
gene polymorphism can be a predisposing
factor for recurrent miscarriage in pregnant
women while the polymorphism of the RAN
gene appears to have no determinant role
(12).
On the other hand, study on miRNA expression
in several organs have shown that miRNA
expression is specific to each tissue and is
abundantly expressed in the placenta (19).
”In addition, miRNAs regulate uterine gene
expression being associated with inflammatory
responses during early implantation and
participate in the maternal-fetal immune tolerance
(20). Furthermore, there is a report suggesting a
link between abnormal miRNA expression and
a large number of human reproductive-related
diseases (21). One study have also reported
genetic polymorphisms being associated with
recurrentmiscarriage (22). Keymolecules involved
in miRNA biogenesis such as XPO5, DROSHA,
DICER have been identified in trophoblast cells
thus confirming the biogenesis pathway as being
active in the human placenta (23).
In addition, a score of investigations have
been performed in Iran and foreign countries
on the association of miRNAs with recurrent
spontaneous abortion, many of which indicate
a significant association between miRNA and
recurrent spontaneous abortion.
5. Conclusion
On the basis of our findings, it seems that RAN
(rs 14035) polymorphism fails to be associated
with the risk of spontaneous abortion in the study
population.
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